• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子κB1 p105通过Tpl2激酶抑制肺癌发生,但与其核因子κB功能无关。

NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.

作者信息

Sun F, Qu Z, Xiao Y, Zhou J, Burns T F, Stabile L P, Siegfried J M, Xiao G

机构信息

University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Department of Microbiology and Molecular Genetics, Hillman Cancer Center Research Pavilion, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

Oncogene. 2016 May 5;35(18):2299-310. doi: 10.1038/onc.2015.299. Epub 2015 Aug 24.

DOI:10.1038/onc.2015.299
PMID:26300007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4548811/
Abstract

Nuclear factor-κB (NF-κB) is generally believed to be pro-tumorigenic. Here we report a tumor-suppressive function for NF-κB1, the prototypical member of NF-κB. While NF-κB1 downregulation is associated with high lung cancer risk in humans and poor patient survival, NF-κB1-deficient mice are more vulnerable to lung tumorigenesis induced by the smoke carcinogen, urethane. Notably, the tumor-suppressive function of NF-κB1 is independent of its classical role as an NF-κB factor, but instead through stabilization of the Tpl2 kinase. NF-κB1-deficient tumors exhibit 'normal' NF-κB activity, but a decreased protein level of Tpl2. Reconstitution of Tpl2 or the NF-κB1 p105, but not p50 (the processed product of p105), inhibits the tumorigenicity of NF-κB1-deficient lung tumor cells. Remarkably, Tpl2-knockout mice resemble NF-κB1 knockouts in urethane-induced lung tumorigenesis. Mechanistic studies indicate that p105/Tpl2 signaling is required for suppressing urethane-induced lung damage and inflammation, and activating mutations of the K-Ras oncogene. These studies reveal an unexpected, NF-κB-independent but Tpl2-depenednt role of NF-κB1 in lung tumor suppression. These studies also reveal a previously unexplored role of p105/Tpl2 signaling in lung homeostasis.

摘要

核因子-κB(NF-κB)通常被认为具有促肿瘤发生作用。在此我们报道了NF-κB的典型成员NF-κB1的肿瘤抑制功能。虽然NF-κB1下调与人类肺癌高风险及患者不良生存相关,但NF-κB1缺陷小鼠对烟雾致癌物乌拉坦诱导的肺肿瘤发生更敏感。值得注意的是,NF-κB1的肿瘤抑制功能独立于其作为NF-κB因子的经典作用,而是通过稳定Tpl2激酶来实现。NF-κB1缺陷肿瘤表现出“正常”的NF-κB活性,但Tpl2蛋白水平降低。重建Tpl2或NF-κB1 p105而非p50(p105的加工产物)可抑制NF-κB1缺陷肺肿瘤细胞的致瘤性。值得注意的是,Tpl2基因敲除小鼠在乌拉坦诱导的肺肿瘤发生方面与NF-κB1基因敲除小鼠相似。机制研究表明,p105/Tpl2信号传导对于抑制乌拉坦诱导的肺损伤和炎症以及激活K-Ras癌基因的突变是必需的。这些研究揭示了NF-κB1在肺肿瘤抑制中一个意想不到的、不依赖NF-κB但依赖Tpl2的作用。这些研究还揭示了p105/Tpl2信号传导在肺稳态中一个此前未被探索的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f727207a593e/nihms706049f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f896d909108d/nihms706049f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f39808d11d7d/nihms706049f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/b1d34293d147/nihms706049f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/eefc33319432/nihms706049f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/cc6cf4579a21/nihms706049f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/114b8eb52067/nihms706049f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f727207a593e/nihms706049f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f896d909108d/nihms706049f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f39808d11d7d/nihms706049f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/b1d34293d147/nihms706049f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/eefc33319432/nihms706049f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/cc6cf4579a21/nihms706049f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/114b8eb52067/nihms706049f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb5d/4548811/f727207a593e/nihms706049f7.jpg

相似文献

1
NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.核因子κB1 p105通过Tpl2激酶抑制肺癌发生,但与其核因子κB功能无关。
Oncogene. 2016 May 5;35(18):2299-310. doi: 10.1038/onc.2015.299. Epub 2015 Aug 24.
2
Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation.癌蛋白激酶Tpl2对NF-κB1/p105的磷酸化作用:Tpl2调控新机制的意义
Biochim Biophys Acta. 2006 Feb;1763(2):174-81. doi: 10.1016/j.bbamcr.2005.12.010. Epub 2006 Jan 13.
3
NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.核因子κB1/p105通过调控Tpl2激酶的稳定性和功能来调节脂多糖刺激的丝裂原活化蛋白激酶信号传导。
Mol Cell. 2003 Mar;11(3):685-94. doi: 10.1016/s1097-2765(03)00070-4.
4
Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection.狂犬病病毒感染期间p105-ABIN2-TPL2复合物和RelAp43对NF-κB的调控
PLoS Pathog. 2017 Oct 30;13(10):e1006697. doi: 10.1371/journal.ppat.1006697. eCollection 2017 Oct.
5
Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.RNA干扰在小鼠巨噬细胞中揭示TLR4和TLR7诱导的NF-κB1 p105-TPL2-ERK通路对肿瘤坏死因子受体相关因子6的敏感性
Mol Immunol. 2007 Jul;44(15):3715-23. doi: 10.1016/j.molimm.2007.04.002. Epub 2007 May 15.
6
IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.白细胞介素-1刺激Tpl2催化亚基活化及其与ABIN2解离所需的不依赖IRAK1的信号通路。
Biochem J. 2009 Oct 23;424(1):109-18. doi: 10.1042/BJ20091271.
7
Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.苏氨酸-290位点的磷酸化调节Tpl2与NF-κB1/p105的结合以及Tpl2的激活和脂多糖诱导的降解。
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2350-5. doi: 10.1073/pnas.0409856102. Epub 2005 Feb 7.
8
Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells.多种Toll样受体利用Tpl2在造血细胞中激活细胞外信号调节激酶(ERK)。
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3274-9. doi: 10.1073/pnas.0511113103. Epub 2006 Feb 16.
9
Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.脂多糖对TPL-2/MEK/细胞外信号调节激酶丝裂原活化蛋白激酶级联反应的激活作用受IkappaB激酶诱导的NF-kappaB1 p105蛋白水解作用调控。
Mol Cell Biol. 2004 Nov;24(21):9658-67. doi: 10.1128/MCB.24.21.9658-9667.2004.
10
TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.TPL-2激酶调节核因子κB抑制蛋白NF-κB1 p105的蛋白水解。
Nature. 1999 Jan 28;397(6717):363-8. doi: 10.1038/16946.

引用本文的文献

1
Unveiling the Novel Anti - Tumor Potential of Digitonin, a Steroidal Saponin, in Gastric Cancer: A Network Pharmacology and Experimental Validation Study.揭示甾体皂苷洋地黄皂苷在胃癌中的新型抗肿瘤潜力:一项网络药理学及实验验证研究
Drug Des Devel Ther. 2025 Apr 5;19:2653-2666. doi: 10.2147/DDDT.S504671. eCollection 2025.
2
NFKB1 as a key player in Tumor biology: from mechanisms to therapeutic implications.NFKB1作为肿瘤生物学中的关键角色:从机制到治疗意义
Cell Biol Toxicol. 2025 Jan 11;41(1):29. doi: 10.1007/s10565-024-09974-2.
3
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2.

本文引用的文献

1
Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.白细胞介素-6可预防肺癌的起始,但会促进其进展。
Cancer Res. 2015 Aug 15;75(16):3209-15. doi: 10.1158/0008-5472.CAN-14-3042. Epub 2015 Jun 29.
2
Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.致癌病毒卡波西肉瘤疱疹病毒(KSHV)抑制肿瘤抑制因子PDLIM2,以持续激活核因子κB(NF-κB)和信号转导子和转录激活子3(STAT3)转录因子,从而促进肿瘤发生和维持肿瘤生长。
J Biol Chem. 2015 Mar 20;290(12):7362-8. doi: 10.1074/jbc.C115.637918. Epub 2015 Feb 13.
3
通过纳米PDLIM2改善PD-1阻断联合化疗实现肺癌完全缓解
Elife. 2024 Dec 24;12:RP89638. doi: 10.7554/eLife.89638.
4
Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis.解析吸烟相关肺癌发生中的核因子κB信号通路
EXCLI J. 2024 Aug 19;23:991-1017. doi: 10.17179/excli2024-7475. eCollection 2024.
5
NF-κB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.NF-κB1 缺失促进巨噬细胞来源的肾上腺肿瘤,但减少 HTLV-I LTR-Tax 转基因小鼠的神经纤维瘤。
PLoS One. 2024 May 9;19(5):e0303138. doi: 10.1371/journal.pone.0303138. eCollection 2024.
6
Critical and distinct roles of cell type-specific NF-κB2 in lung cancer.细胞类型特异性 NF-κB2 在肺癌中具有关键而独特的作用。
JCI Insight. 2024 Feb 22;9(4):e164188. doi: 10.1172/jci.insight.164188.
7
FBXW7 in breast cancer: mechanism of action and therapeutic potential.FBXW7 在乳腺癌中的作用机制和治疗潜力。
J Exp Clin Cancer Res. 2023 Sep 2;42(1):226. doi: 10.1186/s13046-023-02767-1.
8
B cell deficiency promotes the initiation and progression of lung cancer.B细胞缺陷促进肺癌的发生和发展。
Front Oncol. 2022 Sep 29;12:1006477. doi: 10.3389/fonc.2022.1006477. eCollection 2022.
9
Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms.EpCAM在原发性和转移性肺癌中的动态表达受遗传和表观遗传机制共同控制。
Cancers (Basel). 2022 Aug 25;14(17):4121. doi: 10.3390/cancers14174121.
10
Cell adhesion tunes inflammatory TPL2 kinase signal transduction.细胞黏附调节炎症性 TPL2 激酶信号转导。
Cell Mol Life Sci. 2022 Feb 26;79(3):156. doi: 10.1007/s00018-022-04130-7.
Differential roles of STAT3 in the initiation and growth of lung cancer.
信号转导和转录激活因子3(STAT3)在肺癌发生和生长中的不同作用。
Oncogene. 2015 Jul;34(29):3804-3814. doi: 10.1038/onc.2014.318. Epub 2014 Oct 6.
4
IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.IKK是KRAS诱导的、p53活性受干扰的肺癌中的一个治疗靶点。
Genes Cancer. 2014 Apr;5(1-2):41-55. doi: 10.18632/genesandcancer.5.
5
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
6
NF-kappaB in lung tumorigenesis.NF-κB 在肺肿瘤发生中的作用。
Cancers (Basel). 2011 Dec 14;3(4):4258-68. doi: 10.3390/cancers3044258.
7
Chromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancer.染色质结合的 IκBα 在分化和癌症中调节一组 Polycomb 靶基因。
Cancer Cell. 2013 Aug 12;24(2):151-66. doi: 10.1016/j.ccr.2013.06.003. Epub 2013 Jul 11.
8
TPL2 kinase is a suppressor of lung carcinogenesis.TPL2 激酶是肺癌发生的抑制因子。
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):E1470-9. doi: 10.1073/pnas.1215938110. Epub 2013 Mar 26.
9
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.PDLIM2 限制 Th1 和 Th17 分化,防止自身免疫性疾病。
Cell Biosci. 2012 Jun 25;2(1):23. doi: 10.1186/2045-3701-2-23.
10
Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.Tpl2 缺失通过抑制 IL-10 分泌和调节性 T 细胞生成促进 Apcmin 小鼠的肠道炎症和肿瘤发生。
Proc Natl Acad Sci U S A. 2012 May 1;109(18):E1082-91. doi: 10.1073/pnas.1115098109. Epub 2012 Mar 26.